Fortrea Holdings (FTRE) Interest Coverage Ratio Growth (1y) (2023 - 2026)
Fortrea Holdings (FTRE) Interest Coverage Ratio Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | -347.04% |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 73.00% |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | 99.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.04% |
| Dec 31, 2025 | 94.09% |
| Sep 30, 2025 | 46.06% |
| Jun 30, 2025 | -2,582.20% |
| Mar 31, 2025 | -1,937.17% |
| Dec 31, 2024 | -517.09% |
| Sep 30, 2024 | -427.88% |
| Jun 30, 2024 | -295.17% |
| Mar 31, 2024 | -100.53% |
| Dec 31, 2023 | -380.46% |